Skip to main content

Table 3 Summary of the clinical characteristics of the patients referred to the hospital with suspected Acute Hemolytic Anaemia

From: Strengthening therapeutic adherence and pharmacovigilance to antimalarial treatment in Manaus, Brazil: a multicomponent strategy using mHealth

 

Age/Sex

Treatment regimen

Indication

Relevant comorbidities; comedication

G6PD deficiency

Haemolysis

Hemoglobin (g/dL)

Serum bilirubin, total/conjugated, mg/dL

Transaminases (U/L)

Hospitalization period until discharge

(days)

Case 1

11/M

Short standard regimen QC + PQ

Mixed malaria (p.falciparum & vivax)

None; Dipyrone

Yes

No

12.06

1.57/ 0.50

AST: 56

ALT: 30

4 days

Case 2

35/M

Short standard regimen QC + PQ

Malaria p.Vivax

None; Dipyrone

Yes

Yes

12.83

4.65/1.72

AST: 231

ALT: 305

0 days

Case 3

24/F

Short standard regimen QC + PQ

Malaria p.Vivax

None; No

Yes

No

12.38

0.52/0.20

AST: 32

ALT:52

1 day

  1. G6PD: glucose-6-phosphate dehydrogenase; AST, aspartate aminotransferase; ALT, alanine aminotransferase